with the invocell and invo procedure, invo bioscience allows more and more patients to now receive safe, effective and affordable infertility treatment.
Company profile
Ticker
INVO
Exchange
Website
CEO
Steven M. Shum
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
EMY'S SALSA AJI DISTRIBUTION COMPANY, INC.
SEC CIK
Corporate docs
Subsidiaries
Bio X Cell, Inc. • INVO Centers, LLC • Orange Blossom Fertility, LLC • Wood Violet Fertility, LLC ...
INVO stock data
Latest filings (excl ownership)
S-3
Shelf registration
21 May 24
8-K
INVO Reports Record First Quarter 2024 Financial Results
15 May 24
10-Q
2024 Q1
Quarterly report
15 May 24
8-K
Entry into a Material Definitive Agreement
6 May 24
10-K/A
2023 FY
Annual report (amended)
29 Apr 24
8-K
Termination of a Material Definitive Agreement
19 Apr 24
10-K/A
2023 FY
Annual report (amended)
17 Apr 24
8-K
Entry into a Material Definitive Agreement
17 Apr 24
8-K
INVO Reports Fourth Quarter and Full Year 2023 Financial Results
16 Apr 24
10-K
2023 FY
Annual report
16 Apr 24
Transcripts
INVO
Earnings call transcript
2023 Q2
14 Aug 23
INVO
Earnings call transcript
2023 Q2
14 Aug 23
INVO
Earnings call transcript
2023 Q1
15 May 23
INVO
Earnings call transcript
2022 Q4
17 Apr 23
INVO
Earnings call transcript
2022 Q3
15 Nov 22
INVO
Earnings call transcript
2022 Q2
16 Aug 22
INVO
Earnings call transcript
2022 Q1
17 May 22
INVO
Earnings call transcript
2021 Q4
1 Apr 22
INVO
Earnings call transcript
2021 Q3
16 Nov 21
INVO
Earnings call transcript
2021 Q2
17 Aug 21
Latest ownership filings
SC 13G/A
INTRACOASTAL CAPITAL, LLC
6 Feb 24
SC 13G/A
AWM Investment Company, Inc.
8 Sep 23
SC 13G
INTRACOASTAL CAPITAL, LLC
11 Aug 23
4
Matthew K Szot
22 May 23
4
Steve Shum
22 May 23
4
Barbara Ryan
22 May 23
4
Rebecca Messina
22 May 23
4
Andrea Goren
22 May 23
4
TRENT D DAVIS
22 May 23
4
Michael Jos. Campbell
22 May 23
Financial summary
Quarter (USD) | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Institutional ownership, Q2 2023
25.2% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 18 |
Opened positions | 3 |
Closed positions | 7 |
Increased positions | 3 |
Reduced positions | 3 |
13F shares | Current |
---|---|
Total value | 185.92 mm |
Total shares | 960.01 k |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
AWM Investment | 623.86 k | $127.27 mm |
Vanguard | 105.54 k | $21.13 mm |
Geode Capital Management | 87.19 k | $17.79 mm |
Two Sigma Securities | 28.55 k | $5.72 mm |
VIRT Virtu Financial | 24.05 k | $5.00 k |
STT State Street | 23.78 k | $4.85 mm |
Renaissance Technologies | 20.20 k | $4.00 k |
Advisor | 12.18 k | $2.44 mm |
NTRS Northern Trust | 11.41 k | $2.28 mm |
RY Royal Bank Of Canada | 10.77 k | $2.00 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
18 May 23 | Michael Jos. Campbell | Stock Option Common Stock | Grant | Acquire A | No | No | 0.368 | 83,000 | 30.54 k | 83,000 |
18 May 23 | Trent D Davis | Stock Option Common Stock | Grant | Acquire A | No | No | 0.368 | 85,000 | 31.28 k | 85,000 |
18 May 23 | Andrea Goren | Stock option Common Stock | Grant | Acquire A | No | No | 0.368 | 81,000 | 29.81 k | 81,000 |
18 May 23 | Rebecca Messina | Stock Option Common Stock | Grant | Dispose A | No | No | 0.362 | 85,000 | 30.77 k | 85,000 |
18 May 23 | Barbara Ryan | Stock Option Common Stock | Grant | Acquire A | No | No | 0.368 | 85,000 | 31.28 k | 85,000 |
News
INVO Bioscience Q1 EPS $(0.42), Sales $1.58M Up From $348.02K YoY
15 May 24
12 Health Care Stocks Moving In Wednesday's After-Market Session
15 May 24
Peering Into INVO Bioscience's Recent Short Interest
15 May 24
Why Alibaba Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
14 May 24
Why Alcon Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
14 May 24
Press releases
INVO Reports Record First Quarter 2024 Financial Results
15 May 24
Exploring Emerging Companies with Key Developments Garnering Attention: INBS, INVO, VTAK, RCAT, GCTK
19 Apr 24
Micro Cap Massively Bid Up Leading Up To Opening Bell
17 Apr 24
INVO Reports Fourth Quarter and Full Year 2023 Financial Results
16 Apr 24